New dialysis tech aims to improve waste removal for kidney patients
NCT ID NCT06390592
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a new feature called FlexPoint on a peritoneal dialysis machine used at home. The feature adjusts fluid volume and dwell time during treatment. Researchers will compare three different settings in 24 adults with chronic kidney disease to see which works best for removing waste and excess fluid. The goal is to make nightly dialysis more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PD cycler with FlexPoint technology (device)
- What this could lead to
- If successful, this could improve how well peritoneal dialysis removes waste and excess fluid, potentially leading to better daily management of kidney failure.
- What could go wrong
- This is a small, early-stage trial with only 24 participants, so results may not apply to everyone. The technology is a device adjustment, not a new drug or cure, so benefits are likely modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Can a common gout pill shield hearts in kidney disease?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?
- A new pill aims to slow kidney failure and save lives